About Us

Pioneering Innovation in Fully Automated CASA System for Semen Analysis.

Fully Automated CASA System
Benjamin Zhuang - Founder

Benjamin Zhuang: Founder & Chief Developer

  • Education
    B.Eng. in Mechatronics, Nanjing Univ. of Aeronautics & Astronautics
    M.Eng. in Biomedical Engineering (Microfluidics), UNSW, Australia
  • Career
    Early work in aviation manufacturing and micro/nano etching
    Joined Mindray, developed China's first 5-part hematology analyzer
    Led microfluidics R&D at a CAS-affiliated chip company
  • Entrepreneurship
    Founded Create&Care (2016), focused on microfluidic chip industrialization
    Launched Bemaner(SQA-900), a portable AI semen analyzer (iF & Red Dot award); 100K+ users; validated by NUL (PMC7714652)
    Expanded tech to primary care, home diagnostics, and veterinary use
  • Achievements
    National "10,000 Talents Plan" expert; Shenzhen High-Level Talent
    Awards: China Youth Innovation Gold Award, Medical Device Innovation Award
    30+ global patents; dubbed "Inventor of Cell-Level Microfluidic Chips"

Who We Are

iSperm Medical is a pioneering medical technology company dedicated to advancing reproductive medicine through innovation. We specialize in the integration of microfluidic technology, point-of-care testing (POCT), and AI-driven morphological analysis to deliver smart, efficient, and accessible fertility diagnostic solutions.

CASA System Innovation Achievements

Our R&D team developed China's first home-use CASA system in 2017, and the first fully automated CASA system in 2018—marking significant milestones in the evolution of reproductive diagnostics. Our veterinary semen analyzer technology has revolutionized animal reproduction research and diagnostics in China.

Our Mission in Semen Analysis

At iSperm, our mission is to reshape the future of fertility diagnostics with intelligent, user-centric technologies—empowering better health outcomes, supporting reproductive journeys, and contributing to the future of life itself. We are committed to advancing fully automated CASA system technology for comprehensive semen analysis and sperm analyzer applications.

Coming Soon: Human CASA System

iSperm's AI-driven compact fully automated CASA system for human fertility and semen analysis is coming soon in late 2025.

Our Core Values

  • Innovation in CASA Technology
  • Quality Semen Analysis Solutions
  • Customer Focus
  • Professional Excellence